TY - JOUR
T1 - Seasonal changes in indoor airborne fungal concentration in a hematology ward
AU - Mori, Takehiko
AU - Kikuchi, Taku
AU - Kato, Jun
AU - Koda, Yuya
AU - Sakurai, Masatoshi
AU - Kikumi, Osamu
AU - Inose, Rika
AU - Murata, Mitsuru
AU - Hasegawa, Naoki
AU - Nakayama, Hitomi
AU - Yamazaki, Rie
AU - Okamoto, Shinichiro
N1 - Funding Information:
The authors would like to thank Ms. Takako Kasai for kindly providing the surveillance data of pulmonary aspergillosis at Keio University Hospital. This work was partly supported by the research funding from Shionogi & Co., Ltd. , Teijin Pharma , and Japan Blood Products Organization .
Funding Information:
Takehiko Mori received research funding from MSD, Novartis Pharma, LSI Medience, Medical & Biological Laboratories, and Asahi Kasei Corporation, and personal fees from Pfizer Inc., MSD, Janssen Pharma, Sumitomo Dainippon Pharma, Novartis Pharma, Kyowa Kirin, Chugai Pharmaceutical, Shionogi & Co., Japan Blood Products Organization, Takeda Pharmaceutical, Ono Pharmaceutical, Shire, Eisai, and Astellas Pharma; Taku Kikuchi received personal fees from Janssen Pharma; Jun Kato received personal fees from Pfizer Inc., Janssen Pharma, and Astellas Pharma; Naoki Hasegawa received personal fees and research funding from Pfizer Inc., MSD, Daiichi Sankyo Co., Ltd, Taisho Pharmaceutical Co., Ltd.,Eisai Co., Ltd, Sumitomo Dainippon Pharma, and Astellas Pharma, and grant from Insmed Incorporated; Shinichiro Okamoto received research funding from Sumitomo Dainippon Pharma, Pfizer, Teijin pharma, Novartis Pharma, Bristol-Myers Squibb, Mochida Pharmaceutical, JCR Pharmaceuticals, Toyama Chemical, Takeda Pharmaceutical, Daiichi Sankyo, Shionogi & Co., Sanofi, Kyowa Kirin, Ono Pharmaceutical, Otsuka Pharmaceutical, Eisai, Asahi Kasei Corporation, and Japan Blood Products Organization, and personal fees from Pfizer Inc., Janssen Pharma, and Astellas Pharma.The authors would like to thank Ms. Takako Kasai for kindly providing the surveillance data of pulmonary aspergillosis at Keio University Hospital. This work was partly supported by the research funding from Shionogi & Co. Ltd., Teijin Pharma, and Japan Blood Products Organization.
Funding Information:
Takehiko Mori received research funding from MSD , Novartis Pharma , LSI Medience , Medical & Biological Laboratories , and Asahi Kasei Corporation , and personal fees from Pfizer Inc., MSD, Janssen Pharma, Sumitomo Dainippon Pharma, Novartis Pharma, Kyowa Kirin, Chugai Pharmaceutical, Shionogi & Co., Japan Blood Products Organization, Takeda Pharmaceutical, Ono Pharmaceutical, Shire, Eisai, and Astellas Pharma; Taku Kikuchi received personal fees from Janssen Pharma; Jun Kato received personal fees from Pfizer Inc., Janssen Pharma, and Astellas Pharma; Naoki Hasegawa received personal fees and research funding from Pfizer Inc. , MSD , Daiichi Sankyo Co., Ltd , Taisho Pharmaceutical Co., Ltd. , Eisai Co., Ltd , Sumitomo Dainippon Pharma , and Astellas Pharma , and grant from Insmed Incorporated ; Shinichiro Okamoto received research funding from Sumitomo Dainippon Pharma , Pfizer , Teijin pharma , Novartis Pharma , Bristol-Myers Squibb , Mochida Pharmaceutical , JCR Pharmaceuticals , Toyama Chemical , Takeda Pharmaceutical , Daiichi Sankyo, Shionogi & Co. , Sanofi, Kyowa Kirin , Ono Pharmaceutical , Otsuka Pharmaceutical , Eisai , Asahi Kasei Corporation , and Japan Blood Products Organization , and personal fees from Pfizer Inc., Janssen Pharma, and Astellas Pharma.
Publisher Copyright:
© 2019 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases
PY - 2020/4
Y1 - 2020/4
N2 - Invasive fungal disease (IFD) is an important infectious complication of hematological disorders, especially in hematopoietic stem cell transplantation recipients. Evidences suggest seasonal and/or geographical variations in the airborne fungal counts and a relationship between those counts and the incidence of IFD. We evaluated the concentrations of indoor airborne fungi quantitated over the course of one year in a hematology ward in Japan. In January, April, July, and October, fixed volumes of air samples were obtained by an air sampler in a hematology ward not equipped with a high-efficiency particulate air filter and incubated in fugal cultures. Samples were also obtained from a protective environment in the same ward and were evaluated. The number of fungal colonies per 50 L of sampled air was highest in October (median 2.25 (range, 0.2–7.0)), which was significantly higher than those in the other three months (0.1 (range, 0–1.0) in January; 0 (0-0) in April; 0.55 (0–2.5) in July; P < 0.01)). Commonly identified pathogens included Penicillium and Cladosrporium species, but Aspergillus species was detected only in July and October samples. These results suggest a seasonal variation in indoor airborne fungal concentrations in Japan, which could affect the epidemiology of IFD.
AB - Invasive fungal disease (IFD) is an important infectious complication of hematological disorders, especially in hematopoietic stem cell transplantation recipients. Evidences suggest seasonal and/or geographical variations in the airborne fungal counts and a relationship between those counts and the incidence of IFD. We evaluated the concentrations of indoor airborne fungi quantitated over the course of one year in a hematology ward in Japan. In January, April, July, and October, fixed volumes of air samples were obtained by an air sampler in a hematology ward not equipped with a high-efficiency particulate air filter and incubated in fugal cultures. Samples were also obtained from a protective environment in the same ward and were evaluated. The number of fungal colonies per 50 L of sampled air was highest in October (median 2.25 (range, 0.2–7.0)), which was significantly higher than those in the other three months (0.1 (range, 0–1.0) in January; 0 (0-0) in April; 0.55 (0–2.5) in July; P < 0.01)). Commonly identified pathogens included Penicillium and Cladosrporium species, but Aspergillus species was detected only in July and October samples. These results suggest a seasonal variation in indoor airborne fungal concentrations in Japan, which could affect the epidemiology of IFD.
KW - Airborne fungus
KW - Fungus
KW - Hematology ward
KW - Invasive fungal disease
KW - Seasonal change
UR - http://www.scopus.com/inward/record.url?scp=85075888721&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85075888721&partnerID=8YFLogxK
U2 - 10.1016/j.jiac.2019.10.020
DO - 10.1016/j.jiac.2019.10.020
M3 - Article
C2 - 31791593
AN - SCOPUS:85075888721
SN - 1341-321X
VL - 26
SP - 363
EP - 366
JO - Journal of Infection and Chemotherapy
JF - Journal of Infection and Chemotherapy
IS - 4
ER -